WebApr 13, 2024 · Strs Ohio cut its stake in BioMarin Pharmaceutical Inc. ( NASDAQ:BMRN - Get Rating) by 44.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 16,000 shares of the biotechnology company's stock after selling 12,959 shares during the quarter. WebBMRN, BioMarin Pharmaceutical - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines ... BMRN NEWS - IBD PARTNERS; IBD. Earnings Season Preview: Biomarin Pharmaceutical Near Buy Zone With Quarterly Report Due
BMRN -- Is Its Stock Price A Worthy Investment? Learn More.
WebApr 13, 2024 · Strs Ohio cut its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 44.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange ... WebApr 10, 2024 · Morningstar‘s Stock Analysis BMRN Summary Competitors Bulls Say / Bears Say Valuation Feb 28, 2024 Currency in — Is it the right time to buy or sell? Find … red light shades sale
BioMarin Pharmaceutical Inc. (BMRN) Latest Stock News
WebMar 21, 2024 · Get the latest news and real-time alerts from BioMarin Pharmaceutical Inc. (BMRN) stock at Seeking Alpha. BioMarin Pharmaceutical Inc. (BMRN) Latest Stock … WebApr 12, 2024 · BioMarin Pharmaceutical had a return on equity of 3.73% and a net margin of 6.75%. Equities analysts predict that BioMarin Pharmaceutical Inc. will post 1.17 earnings per share for the current year. Insider Buying and Selling. In other news, CFO Brian Mueller sold 2,500 shares of the stock in a transaction dated Friday, January 13th. … WebView the latest BioMarin Pharmaceutical Inc. (BMRN) stock price, news, historical charts, analyst ratings and financial information from WSJ. BMRN BioMarin Pharmaceutical … richard harold